Please check your internet connection and try again.
# Isoxsuprine hydrochloride
## Overview
Isoxsuprine is a beta-adrenergic agonist that acts as a vasodilator by directly relaxing vascular smooth muscle. Historically used for peripheral vascular disease and premature labor (tocolysis), it is now largely considered obsolete in many modern clinical settings due to limited efficacy data and the availability of superior therapeutic alternatives.
## Primary Indications
* Cerebrovascular insufficiency (historical).
* Peripheral vascular disease (e.g., arteriosclerosis obliterans, Buerger's disease, Raynaud's phenomenon).
* Premature labor (Note: Use for tocolysis is generally contra-indicated or discouraged by current clinical guidelines due to maternal cardiovascular risks).
## Adult Dosing
* **Peripheral Vascular Disease:** 10–20 mg orally 3 to 4 times daily.
* **Maximum Dose:** 80 mg/day.
* *Note: Dosing varies significantly by institutional protocol and regional availability.*
## Pediatric Dosing
Safety and efficacy have not been established in pediatric populations. Use is not recommended.
## Dose Adjustments
* **Renal/Hepatic Impairment:** No standardized guidelines exist; use with extreme caution or avoid due to systemic vasodilation potential.
* **Geriatric:** Increased risk of orthostatic hypotension; start at the lowest effective dose.
## Contraindications
* Immediately postpartum.
* Presence of arterial bleeding.
* Recent myocardial infarction.
* Hypersensitivity to isoxsuprine or other beta-agonists.
* Severe cardiac arrhythmias or thyrotoxicosis.
## Adverse Effects
* **Common:** Hypotension, tachycardia, palpitations, dizziness, flushing, tremor.
* **Gastrointestinal:** Nausea, vomiting, abdominal distress.
* **Severe:** Pulmonary edema (especially in obstetric use), chest pain, maternal/fetal tachycardia, rashes.
## Key Drug Interactions
* **Antihypertensives:** Synergistic hypotensive effect; close monitoring of blood pressure required.
* **Sympathomimetics:** May increase the risk of cardiac arrhythmias or excessive tachycardia.
* **General Anesthetics:** May increase the sensitivity of the myocardium to the effects of beta-agonists.
## Monitoring
* Baseline and periodic monitoring of blood pressure and heart rate.
* Monitor for signs of pulmonary edema (dyspnea, crackles) if used in high-risk patients.
* Baseline ECG if cardiac history is present.
## Clinical Pearls
* **Efficacy:** Evidence for its clinical benefit in peripheral vascular disease is weak. Consider vasodilator alternatives like cilostazol or pentoxifylline.
* **Tocolysis:** Use in obstetrics has been largely abandoned in favor of nifedipine, magnesium sulfate, or oxytocin receptor antagonists due to maternal safety profile.
* **Administration:** May be taken with food to reduce gastrointestinal upset.
***
**Educational Disclaimer:** This information is for educational purposes only. Clinical practice guidelines vary by region and institution. Always verify specific dosing, safety precautions, and current prescribing information against your local formulary and the most recent package insert before administration.
